Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder

Last updated: May 27, 2019
Sponsor: Hospital de Clinicas de Porto Alegre
Overall Status: Active - Recruiting

Phase

4

Condition

Williams Syndrome

Attention Deficit/hyperactivity Disorder (Adhd - Adults)

Treatment

N/A

Clinical Study ID

NCT02737020
150425
  • Ages > 18
  • All Genders

Study Summary

This study evaluates the use of Rhodiola rosea in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) in adults. Half of participants will receive Rhodiola rosea, while the other half will receive placebo.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Fulfillment of Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, (DSM-5) diagnostic criteria for ADHD in Adults

  • Intelligence Quotient (IQ) above 70

  • Eligibility to Rhodiola rosea

Exclusion

Exclusion Criteria:

  • clinical contraindication fro Rhodiola rosea -

  • any unstable chronic illness without proper treatment (hypertension, heart, kidney orliver disease)

  • any significant neurological disease (delirium, dementia, epilepsy, AIDS, head trauma,multiple sclerosis, stroke, etc)

  • unstable psychiatric comorbidities requiring immediate treatment (risk of suicide,current Substance Use Disorder, etc.)

  • pregnant, nursing or absence of reliable contraception

  • current use of nicotine (<30 days)

  • use of anticoagulants

  • current use of any psychoactive drug (<30 days)

  • prior use of stimulants

  • current or lifetime psychosis- current or lifetime bipolar disorder

Study Design

Total Participants: 60
Study Start date:
April 01, 2016
Estimated Completion Date:
March 31, 2021

Study Description

Rhodiola rosea is an herbal medicine used for centuries in various medical conditions. Many randomized controlled trials have evaluated its usefulness in stress and fatigue. There were benefits in attention in some of these studies. Mild side effects and beneficial antioxidant properties make reasonable an assessment of its potential benefits in adults with ADHD. To our knowledge, Rhodiola rosea was never studied in ADHD.

Connect with a study center

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande Do Sul 90035-903
    Brazil

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.